The rapid emergence of a large number of NPS on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social harms of NPS, which pose a considerable challenge for prevention and treatment. The analysis and identification of a large number of chemically diverse substances present in drug markets at the same time is demanding. Monitoring, information sharing, early warning and risk awareness are essential to respond to this situation. Read more